ICD-11 Codes
for MA12.Y - Other specified clinical findings of drugs, medicaments and biological substances in blood, blood-forming organs, or the immune system

Teodor Jurukovski January 1, 1970

Fact checked by: Teodor Jurukovski

Use Code

Understanding ICD-11 Code MA12.Y: Clinical Findings of Substances

ICD-11 code MA12.Y, officially titled "Other specified clinical findings of drugs, medicaments and biological substances in blood, blood-forming organs, or the immune system," represents specific laboratory or clinical observations. This code is used to document findings related to drugs, medicaments, or biological substances detected within a patient's blood, blood-forming organs, or immune system, when these findings are not part of a more specific diagnostic category.

Synonyms and Alternative Terms for MA12.Y

This clinical finding may also be referred to by terms such as:

• Specified drug findings in blood
• Medicament detection in blood, blood-forming organs, or immune system
• Biological substance findings in blood or immune system
• Other specified substance findings in blood
• ICD-11 code for drug presence in blood

How is MA12.Y Diagnosed?

The identification of MA12.Y is based on laboratory analysis. Diagnosis involves detecting the presence of specified drugs, medicaments, or biological substances in a patient's blood, blood-forming organs, or immune system. These findings are typically identified through various diagnostic tests, such as blood work or immunological assays, when the specific substance or its clinical significance is noted but does not fit into a more defined disorder code.

Documentation and Coding Considerations for MA12.Y

As a code for clinical findings, MA12.Y is often used as a secondary code to provide additional detail about a patient's condition or test results. It is important for healthcare providers to document the specific substance identified and the context of the finding. This code is typically used when a specific drug, medicament, or biological substance is detected, and it is clinically relevant, but does not constitute a disorder in itself. Accurate documentation supports precise medical billing and record-keeping.

When to Seek Medical Advice

Patients should consult a healthcare professional if they have received results indicating the presence of specified drugs, medicaments, or biological substances in their blood, blood-forming organs, or immune system. This is particularly important if these findings are unexpected, if they are related to potential exposure, or if they are part of an ongoing health investigation. Prompt medical evaluation can help determine the significance of these findings and guide appropriate management.

Is ICD-11 Code MA12.Y Billable or Reportable?

ICD-11 code MA12.Y, representing specified clinical findings, is generally reportable when it contributes to the patient's diagnosis, treatment, or management plan. Its billability depends on payer policies and the specific clinical context in which the finding is relevant. Healthcare providers should verify with their billing department or relevant authorities regarding specific reporting and billing requirements for clinical findings codes.